These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 8867866)
1. Bone marrow gene transfer in three patients with adenosine deaminase deficiency. Hoogerbrugge PM; van Beusechem VW; Fischer A; Debree M; le Deist F; Perignon JL; Morgan G; Gaspar B; Fairbanks LD; Skeoch CH; Moseley A; Harvey M; Levinsky RJ; Valerio D Gene Ther; 1996 Feb; 3(2):179-83. PubMed ID: 8867866 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow gene therapy for adenosine deaminase deficiency. Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479 [TBL] [Abstract][Full Text] [Related]
3. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060 [TBL] [Abstract][Full Text] [Related]
8. The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells. Chertkov JL; Jiang S; Lutton JD; Harrison J; Levere RD; Tiefenthaler M; Abraham NG Stem Cells; 1993 May; 11(3):218-27. PubMed ID: 8318909 [TBL] [Abstract][Full Text] [Related]
9. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation. Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905 [TBL] [Abstract][Full Text] [Related]
10. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments]. Smogorzewska EM; Weinberg KI; Kohn DB Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167 [TBL] [Abstract][Full Text] [Related]
11. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID. Taupin P IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313 [TBL] [Abstract][Full Text] [Related]
12. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors. Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727 [TBL] [Abstract][Full Text] [Related]
14. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992. Blaese RM; Culver KW; Chang L; Anderson WF; Mullen C; Nienhuis A; Carter C; Dunbar C; Leitman S; Berger M Hum Gene Ther; 1993 Aug; 4(4):521-7. PubMed ID: 7691188 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for hematopoietic and immune disorders. Kohn DB Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410 [TBL] [Abstract][Full Text] [Related]
16. Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates. Hanazono Y; Terao K; Shibata H; Nagashima T; Ageyama N; Asano T; Ueda Y; Kato I; Kume A; Hasegawa M; Ozawa K J Gene Med; 2002; 4(5):470-7. PubMed ID: 12221639 [TBL] [Abstract][Full Text] [Related]
17. In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model. Hanazono Y; Nagashima T; Takatoku M; Shibata H; Ageyama N; Asano T; Ueda Y; Dunbar CE; Kume A; Terao K; Hasegawa M; Ozawa K Gene Ther; 2002 Aug; 9(16):1055-64. PubMed ID: 12140733 [TBL] [Abstract][Full Text] [Related]
19. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions. Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386 [TBL] [Abstract][Full Text] [Related]
20. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency. Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]